Request Your Free Information Brief Now:

"Accelerate Genomic Insights for Drug Discovery with IQVIA Laboratories Bioinformatics Solutions"

Ready to accelerate your drug development and harmonize your global data strategy?

In the competitive landscape of pharmaceutical and biotechnology innovation, Next Generation Sequencing (NGS) is a powerful tool for uncovering genomic biomarkers, characterizing disease mechanisms, and informing targeted therapy development. Yet, the path from raw FASTQ files to actionable insights often stalls at the bioinformatics stage—delaying critical decisions in translational research and clinical development.

Facing delays in your sequencing data analysis? At IQVIA Laboratories, we understand the urgency of your pipeline. Our platform offers fast, scalable, and compliant end-to-end secondary analysis workflows, including:

• Variant calling
• Gene expression profiling
• Fusion detection
• Copy number variation analysis

By streamlining genomic data processing, we enable pharma and biotech teams to focus on what matters most: identifying therapeutic targets, validating biomarker signatures, and accelerating clinical trial readiness.

Discover how IQVIA Laboratories Bioinformatics transforms NGS data into meaningful insights—faster.

Offered Free by: IQVIA Laboratories
See All Resources from: IQVIA Laboratories